| Chapter title |
Irreversibility of Symptoms with Biotin Therapy in an Adult with Profound Biotinidase Deficiency
|
|---|---|
| Chapter number | 12 |
| Book title |
JIMD Reports, Volume 36
|
| Published in |
JIMD Reports, January 2017
|
| DOI | 10.1007/8904_2017_12 |
| Pubmed ID | |
| Book ISBNs |
978-3-66-256137-9, 978-3-66-256138-6
|
| Authors |
Patrick Ferreira, Alicia Chan, Barry Wolf, Ferreira, Patrick, Chan, Alicia, Wolf, Barry |
| Abstract |
We report a 36-year-old woman who exhibited progressive optic atrophy at 13 years old, then stroke-like episodes and spastic diplegia in her 20s. Biotinidase deficiency was not readily considered in the differential diagnosis, and the definitive diagnosis was not made until pathological variants of the biotinidase gene (BTD) were found by exome sequencing. Profound biotinidase deficiency was confirmed by enzyme analysis. Unfortunately, her symptoms did not resolve or improve with biotin treatment. Biotin therapy is essential for all individuals with profound biotinidase deficiency and for preventing further damage in those who already exhibit irreversible neurological damage. Newborn screening for the disorder would have avoided years of clinical symptoms that now appear to be irreversible with biotin treatment. |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 10 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 3 | 30% |
| Student > Postgraduate | 3 | 30% |
| Unknown | 4 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 2 | 20% |
| Neuroscience | 2 | 20% |
| Agricultural and Biological Sciences | 1 | 10% |
| Immunology and Microbiology | 1 | 10% |
| Unknown | 4 | 40% |